News

Cancer treatment could set back patients by up to $20,000 per year, with the entire treatment duration possibly reaching more than a million dollars. Many who suffer from the condition are not only experiencing the physical and emotional pain...

We have all been there: a nagging head cold or sinus pressure hits right before a weekend plan or social gathering. It is incredibly tempting to take a Sudafed to clear your head and go out anyway, assuming a...

The U.S. Food and Drug Administration on Tuesday authorized the use of leucovorin, a long-established generic medicine, for the treatment of a rare genetic disorder associated with autism-like symptoms. The decision does not extend to children diagnosed with autism...

The UK government and national regulators have introduced a coordinated regulatory roadmap aimed at enabling space-based drug manufacturing, marking a significant step toward commercialising drug production in microgravity environments. The initiative brings together the UK Space Agency, the Medicines...

The pharmaceutical industry is dynamically changing. So, technological advances are critical. This is because they enhance efficiencies in production. The demand for high-quality drugs is ever-increasing. This means pharmaceutical companies encounter different challenges. Among the most important answers to these...

The global life sciences industry must remain competitive to sustain growth. Attracting employees to sales teams may require new strategies in the coming year. Understanding how the biggest companies are building their commercial teams will help you make life...

The supplemental Biologics License Application - sBLA for Enhertu - trastuzumab deruxtecan by AstraZeneca and Daiichi Sankyo has been accepted as well as granted Priority Review in the U.S. when it comes to the treatment of adult patients with...